SLC2A1 and cancer: In this regard, we observed that glyCAF exhibit the strongest blocking of CD8+ T cell migration toward the tumor cells compared to the non-glyCAF, Ccne1+ cancer cells, and macrophages (Fig. 5c), Then, we investigated whether blocking GLUT1 in the glyCAF impacts their functions.